WORKING WITH US
Grow your career with ARBORMED
Innovative new drug - starting from mid preclinical stage, develop best in class therapies with validated targets with a particular focus on rare diseases
Methanobactin
Wilson's Disease
It is a drug candidate with novel mode of action that prevents or stops WD liver damage from worsening by facilitating copper excretion
Pendrin Inhibitor
Acute Respiratory Distress Syndrome
(ARDS)It’s a first-in-class pendrin inhibitor to treat ARDS by reducing the expression of pendrin and its anion exchange activity in the alveolar epithelial cells and blocking the downstream signaling pathway and inflammation
Pendrin corrector
Pendred Syndrome
It is designed to rescue pendrin protein from degradation by correcting its conformation of the mutated pendrin protein retained in the ER thereby allowing its targeting to the cell surface with further post-translational modifications in the TGN on the way
Undisclosed
Undisclosed
We will create success stories with strategic partners with common goal and vision.
Bringing you the latest news from ARBORMED
Careers with ARBORMED
History of ARBORMED
Location
Arbormed Co., Ltd - 7th fl., 12, Nonhyeon-ro 81-gil, Gangnam-gu, Seoul 06237 Korea
02-6953-1207
sseong@arbormed.com
Alpha Tower 202, Pangyoyeok-ro 180, Bundang-gu, Seongnam-si, Gyeonggi-do 13524 Korea
031-8039-6219
sseong@arbormed.com
611 Gateway Boulevard Suite 120 San Francisco, California 94080 USA
+1 650-861-1353
sseong@arbormed.com